| scholarly article | Q13442814 |
| P2093 | author name string | Miyashita Y | |
| Ohtsuka M | |||
| Oyama T | |||
| Koide N | |||
| Shirai K | |||
| Ohhira M | |||
| Endoh K | |||
| Saiki A | |||
| Nagayama D | |||
| P2860 | cites work | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 |
| Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage | Q28645856 | ||
| Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group | Q29617736 | ||
| Obesity-related glomerulopathy: an emerging epidemic | Q34190647 | ||
| Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study | Q34720231 | ||
| Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments] | Q38321070 | ||
| Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity | Q38340354 | ||
| How to protect the kidney in diabetic patients: with special reference to IDDM. | Q41585880 | ||
| Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies | Q44293250 | ||
| Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome | Q44674459 | ||
| Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. | Q44865539 | ||
| Restriction of dietary protein and progression of renal failure in diabetic nephropathy | Q44912088 | ||
| Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus | Q46534931 | ||
| Effects of Body-Weight Loss and Captopril Treatment on Proteinuria Associated with Obesity | Q61456164 | ||
| Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy | Q70517084 | ||
| Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes | Q71909309 | ||
| Renal effects of different types of protein in healthy volunteer subjects and diabetic patients | Q72930062 | ||
| The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity | Q73949603 | ||
| Salt intake and renal outcome in patients with progressive renal disease | Q74469075 | ||
| Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy | Q77602671 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| patient | Q181600 | ||
| P304 | page(s) | 1115-1120 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | International Journal of Obesity | Q6051519 |
| P1476 | title | Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy | |
| P478 | volume | 29 |
| Q38841612 | A systematic review and meta-analysis on the effects of exercise training versus hypocaloric diet: distinct effects on body weight and visceral adipose tissue |
| Q37258125 | Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study |
| Q85015792 | Benefits of Staple Food Restriction for Japanese Obese Patients With Chronic Kidney Disease: A Pilot Study |
| Q41828830 | Body weight control by a high-carbohydrate/low-fat diet slows the progression of diabetic kidney damage in an obese, hypertensive, type 2 diabetic rat model |
| Q53519441 | Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min). |
| Q37511029 | Consequences of morbid obesity on the kidney. Where are we going? |
| Q38109814 | Diabetes and its comorbidities--where East meets West |
| Q33583018 | Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis |
| Q31157315 | Dietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data. |
| Q34572119 | Dietary restriction and exercise for diabetic patients with chronic kidney disease: a systematic review |
| Q34722642 | Dissecting the mechanisms of left ventricular diastolic dysfunction and inflammation in peritoneal dialysis patients |
| Q35938045 | Early chronic kidney disease: diagnosis, management and models of care |
| Q44896182 | Early improvement in albuminuria in non-diabetic patients after Roux-en-Y bariatric surgery |
| Q37155484 | Effect of Regular Exercise on the Histochemical Changes of d-Galactose-Induced Oxidative Renal Injury in High-Fat Diet-Fed Rats |
| Q89256621 | Effects of Low-Protein Diet on lipid and anthropometric profiles of patients with chronic kidney disease on conservative management |
| Q87786140 | Effects of a Multicomponent Life-Style Intervention on Weight, Glycemic Control, Depressive Symptoms, and Renal Function in Low-Income, Minority Patients With Type 2 Diabetes: Results of the Community Approach to Lifestyle Modification for Diabetes |
| Q38149111 | Effects of weight loss on renal function in obese CKD patients: a systematic review |
| Q36554341 | Emerging global epidemic of obesity: the renal perspective |
| Q40436924 | Estimated GFR Before and After Bariatric Surgery in CKD. |
| Q84978295 | Evidence-based practice guideline for the treatment of CKD |
| Q36458435 | Impact of Lifestyle Modification on Diabetic Kidney Disease |
| Q33707463 | Interaction of obesity and central obesity on elevated urinary albumin-to-creatinine ratio |
| Q92702386 | Lipid Accumulation and Chronic Kidney Disease |
| Q47108672 | Long-Term Normal Renal Function after Drastic Weight Reduction in Patients with Obesity-Related Glomerulopathy |
| Q27027141 | Management of obesity-induced kidney disease: a critical review of the literature |
| Q34075430 | Obesity-related glomerulopathy: body mass index and proteinuria |
| Q30249819 | Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. |
| Q48698019 | Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment |
| Q36966082 | Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity |
| Q30422206 | Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature |
| Q37280851 | Short-term changes after a weight reduction intervention in advanced diabetic nephropathy |
| Q40049756 | The Why WAIT program: improving clinical outcomes through weight management in type 2 diabetes |
| Q37976970 | The effect of weight loss in obesity and chronic kidney disease |
| Q36197733 | The effects of weight change on glomerular filtration rate |
| Q33671044 | The effects on oxidative DNA damage of laparoscopic gastric band applications in morbidly obese patients |
| Q37050229 | The extinguished BEACON of bardoxolone: not a Monday morning quarterback story |
| Q38429861 | The kidney in obesity |
| Q34632532 | The relationship between obesity and diabetic nephropathy in China |
| Q33937580 | Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery |
| Q47318326 | Weight Loss Mediated Reduction in Xanthine Oxidase Activity and Uric Acid Clearance in Adolescents with Severe Obesity |
| Q37640916 | Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. |
| Q40837060 | Weight loss for reduction of proteinuria in diabetic nephropathy: Comparison with angiotensin-converting enzyme inhibitor therapy |
| Q38539937 | Weight loss interventions and progression of diabetic kidney disease |
| Q35006811 | Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis |
Search more.